Daewoong Pharmaceuticals Co., Ltd pursues meaningful work by collaborating with great people, working with autonomy, and choosing opportunities that create shared value for the company, customers, and society. Above all, we are committed to driving real change and innovation through what we do. Establish in 1945, Daewoong Pharmaceuticals is a leading healthcare company in Korea that has achieved consecutive successes in new drug development through constant challenge and innovation. Today, we continue to expand a diverse pipeline and next-generation platform technologies, aiming to develop first-in-class and best-in-class innovative medicines for patients worldwide. Our commitment to global standards is proven by GMP certifications from major regulatory authorities such as the U.S. FDA and EMA, along with ISO certifications that demonstrate our excellence in quality, environmental management, and occupational health and safety systems. At Daewoong, we believe that the growth of our employees fuels the growth of the company. We foster a forward-looking corporate culture by promoting smart work practices, career development, and global talent training programs. Beyond Korea, we strive to become a global healthcare leader by creating new value for healthier lives and better quality of life worldwide.
Unlock the market timeline & signal feed
92 signals in the last 90 days.
The order this company entered each market — oldest to newest
Sign up to see the full signal feed
How Daewoong Pharmaceutical's international expansion compares to its competitors
Daewoong PharmaceuticalYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Daewoong PharmaceuticalYou | 2 | 0 | -88% | 92 | 41 |
Senior Partnership & Leasing - Bali
View postingKuta, Bali, Indonesia · 5mo ago
Chief Engineer - Bali
View postingKuta, Bali, Indonesia · 5mo ago
Cafe Team
View postingKuta, Bali, Indonesia · 6mo ago
#News 📢 대웅제약 presented integrated model-based research findings on its SGLT-2 inhibitor #Enavogliflozin, at the 2026 PAGE (PAGE - Population Approach Group Europe) conference, a leading European forum in quantitative pharmacology.This study quantitatively elucidated the causal relationship between increased urinary glucose excretion following drug administration and the reduction in glycated hemoglobin (HbA1c), and scientifically demonstrated that the absence of significant pharmacokinetic diff ...
EndedNot all long-acting depot platforms are created equal. The key lies in how efficiently a drug can be delivered — in a smaller volume.In Episode 2 of the "Maximizing Therapeutic Potential with CURE®" series, we explore how CURE® achieves industry-leading drug loading to deliver a once-monthly therapeutic dose with up to 4–5× less depot mass than competing platforms.#Daewoong #GLP1 #CURE #platform #obesity #diseases #longactinginjectables ...
EndedSmall differences in wording can easily lead to misunderstandings in pharmaceutical communication.✍️👩💻Ji Young Yoon from 대웅제약’s Medical Team took on the challenge of bringing clarity to the confusion surrounding UDCA-related scientific messages, which had been spreading across multiple channels during the pandemic. By restructuring the messaging system, she helped ensure that accurate, evidence-based information could be delivered consistently.Curious about her journey? Watch the full video no ...
ActiveFinancial leaders visited Daewoong Pharmaceutical's smart factory in Osong to explore innovation potential for the National Growth Fund in the pharmaceutical industry.
Daewoong Pharma launched two health supplements: an antioxidant for adults and an immunity booster for children under its Mentolife brand.
Daewoong Pharma aims for 300 billion won in digital healthcare sales this year, unveiling an integrated AI healthcare platform and plans for nationwide remote health monitoring.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Daewoong Pharmaceutical's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
